Amplification of EGFR is noted in over 50% of glioblastoma cases [6], and has tumor-promoting effects on multiple downstream signaling pathways that are linked to proliferation, angiogenesis, fatty acid synthesis, infiltration, and apoptosis [7,8,9,10]. The gene discussed is EGFR; the disease is neoplasm.